Statements (31)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:approvalYear |
2018
|
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:ATCCode |
L01EM03
|
| gptkbp:CASNumber |
1201438-56-3
|
| gptkbp:chemicalFormula |
C22H17ClN6O
|
| gptkbp:genericName |
gptkb:duvelisib
|
| gptkbp:hasBoxedWarning |
diarrhea
infections hepatotoxicity inflammatory bowel disease pneumonitis |
| gptkbp:hasFormerManufacturer |
gptkb:Verastem
|
| https://www.w3.org/2000/01/rdf-schema#label |
Copiktra
|
| gptkbp:indication |
gptkb:small_lymphocytic_lymphoma
chronic lymphocytic leukemia follicular lymphoma |
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
Secura Bio
|
| gptkbp:mechanismOfAction |
PI3K inhibitor
|
| gptkbp:pregnancyCategory |
not recommended
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
diarrhea
infections rash hepatotoxicity neutropenia |
| gptkbp:synonym |
gptkb:duvelisib
IPI-145 |
| gptkbp:bfsParent |
gptkb:duvelisib
|
| gptkbp:bfsLayer |
5
|